# The Effect of NAD Supplementation on Brain Vascular Health in Aging

> **NCT05483465** · PHASE4 · RECRUITING · sponsor: **University of Oklahoma** · enrollment: 214 (estimated)

## Conditions studied

- Aging

## Interventions

- **DRUG:** Nicotinamide riboside
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05483465
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-03
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 214 (ESTIMATED)
- **Last updated:** 2026-04-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05483465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05483465, "The Effect of NAD Supplementation on Brain Vascular Health in Aging". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05483465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*